Back to trial detailsIntake questionnaire
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
Applying to Bridge HIV CRS Site# 30305 · San Francisco, California
Answer a few short questions to share with the research team.
0 of 2 answered